Cable Hill Partners, LLC Cyma Bay Therapeutics, Inc. Transaction History

Cable Hill Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$6.05 - $13.66 $1,167 - $2,636	-193 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$10.88 - $14.52 $2,099 - $2,802	193 New	193 $2,000
Q1 2018 Apr 20, 2018	SELL	$9.0 - $15.16 $4,500 - $7,580	-500 Closed	0 $0
Q4 2017 Feb 22, 2018	BUY	$7.67 - $9.31 $3,835 - $4,655	500	500 $5,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.